𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor suppressor function of Rab25 in triple-negative breast cancer

✍ Scribed by Ji-Ming Cheng; Lisa Volk; Deepak Kumar Mummidavarapu Janaki; Sudhir Vyakaranam; Sophia Ran; Krishna A. Rao

Publisher
John Wiley and Sons
Year
2010
Tongue
French
Weight
879 KB
Volume
126
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Rab proteins are a group of ubiquitously expressed proteins that are responsible for intracellular transport of vesicles. Recent evidence has shown that certain Rab proteins are involved in the pathogenesis of cancer. We have recently shown that Rab25 is lost in a large fraction of breast cancer samples, particularly those derived from hormonally insensitive tumors. We have further investigated the role of Rab25 by re‐expressing Rab25 in tumorigenic cell lines and measuring the impact on tumor formation as well as on various molecular pathways through PCR array analysis. In vivo tumor growth of cell lines with re‐expressed Rab25 was markedly suppressed. Our data suggest that Rab25 acts through multiple pathways to enhance apoptosis and to suppress angiogenesis and invasion by modulating VEGF‐A and VEGFR‐1 expression. These findings suggest that Rab25 represents a novel class of cellular modulators that can influence both tumor initiation and the progression of the established tumors, thus ultimately affecting the biology of the malignant disease.

📜 SIMILAR VOLUMES

Loss of RAB25 expression in breast cance
Loss of RAB25 expression in breast cancer
✍ Ji-Ming Cheng; Ming Ding; Ahmed Aribi; Prabodh Shah; Krishna Rao 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 329 KB

## Abstract A novel breast cancer cell line (RAO‐3) was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (__hTERT__). The cells displayed anchorage‐independent growth and proliferation, and formed huma

High prevalence of triple-negative tumor
High prevalence of triple-negative tumors in an urban cancer center
✍ Mary Jo B. Lund; Ebonee N. Butler; Harvey L. Bumpers; Joel Okoli; Monica Rizzo; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract ## BACKGROUND. A disparate proportion of breast cancer deaths occur among young women, those of African‐American (AA) ancestry, and particularly young AA women. Estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor‐2 (HER‐2) are key clinically

Identification of Fat4 as a candidate tu
Identification of Fat4 as a candidate tumor suppressor gene in breast cancers
✍ Chao Qi; Yiwei Tony Zhu; Liping Hu; Yi-Jun Zhu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 382 KB 👁 3 views

## Abstract __Fat__, a candidate tumor suppressor in __Drosophila__, is a component of Hippo signaling pathway involved in controlling organ size. We found that a ∼3 Mbp deletion in mouse chromosome 3 caused tumorigenesis of a non‐tumorigenic mammary epithelial cell line. The expression of __Fat4__